KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer
Zhongyin Yang(Shanghai Jiao Tong University), Qinlong Gu(Shanghai Jiao Tong University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Min Yan(Zhengzhou University), Jianfang Li(Shanghai Jiao Tong University), Yingli Wu(University of Cambridge), Bingya Liu(Shanghai Jiao Tong University), Chen Li(Shanghai Jiao Tong University), Chao Yan(Shanghai Jiao Tong University)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
November 4, 2018
Cited by 110
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231
Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
|World Journal of Gastroenterology|2018|212